Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter VEGF (Bevacizumab Biosimilar) Antikörper

Reaktivität: Human FACS, ELISA, BR, IP, WB Wirt: Kaninchen Chimeric unconjugated Recombinant Antibody
Produktnummer ABIN5668151
  • Target Alle VEGF (Bevacizumab Biosimilar) Produkte
    VEGF (Bevacizumab Biosimilar)
    Antikörpertyp
    Recombinant Antibody
    Reaktivität
    Human
    Wirt
    • 2
    • 1
    • 1
    • 1
    Kaninchen
    Klonalität
    • 4
    • 1
    Chimeric
    Konjugat
    • 5
    Dieser VEGF (Bevacizumab Biosimilar) Antikörper ist unkonjugiert
    Applikation
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    Flow Cytometry (FACS), ELISA, Blocking Reagent (BR), Immunoprecipitation (IP), Western Blotting (WB)
    Verwendungszweck
    Anti-VEGF [Bevacizumab], Rabbit IgG, kappa
    Spezifität
    This antibody binds native and reduced human VEGF (isoform 165).
    Produktmerkmale

    Original Species of Ab: Human

    Original Format of Ab: IgG1

    Aufreinigung
    Protein A affinity purified
    Reinheit
    > 98 % as determined by SDS-PAGE
    Endotoxin-Niveau
    Endotoxin is < 1.0 EU/mg as determined by the LAL method
    Immunogen
    Recombinant human VEGF.
    Isotyp
    IgG kappa
  • Applikationshinweise
    This is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.
    Kommentare

    NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1 mg/mL
    Buffer
    PBS with 0.02 % Proclin 300.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target
    VEGF (Bevacizumab Biosimilar)
    Abstract
    VEGF (Bevacizumab Biosimilar) Produkte
    Hintergrund
    Ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF
    UniProt
    P15692
Sie sind hier:
Kundenservice